<code id='42B24FE483'></code><style id='42B24FE483'></style>
    • <acronym id='42B24FE483'></acronym>
      <center id='42B24FE483'><center id='42B24FE483'><tfoot id='42B24FE483'></tfoot></center><abbr id='42B24FE483'><dir id='42B24FE483'><tfoot id='42B24FE483'></tfoot><noframes id='42B24FE483'>

    • <optgroup id='42B24FE483'><strike id='42B24FE483'><sup id='42B24FE483'></sup></strike><code id='42B24FE483'></code></optgroup>
        1. <b id='42B24FE483'><label id='42B24FE483'><select id='42B24FE483'><dt id='42B24FE483'><span id='42B24FE483'></span></dt></select></label></b><u id='42B24FE483'></u>
          <i id='42B24FE483'><strike id='42B24FE483'><tt id='42B24FE483'><pre id='42B24FE483'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:73393
          People waiting in line, standing in between red rope. -- first opinion coverage from STAT
          Adobe

          Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

          The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

          advertisement

          For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati
          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

          CourtesyBristolMyersSquibbBristolMyersSquibbsaidthatitwouldpurchaseMiratiTherapeutics,makerofthecanc

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          Why Charlie Gard's case is so disturbing to Americans

          ConnieYates,motherofterminallyillbabyCharlieGard,carriesastuffedanimalafterdeliveringapetitionofsign